Couple of points if I may
Firstly I agree with you all that a spp for holders should've been offered and imo this would've also been over-subscribed with the additional bonus option. If the capital was required urgently then we should perhaps be expecting positive news to justify this raising?
On doing a quick search for quoted options within the biotech sector I just noted the following:
Search
Code or Company Name: pyc
Industry: Biotechnology & Life Sciences
Type: Company Option
__________
Code Name
PYCOA PHYLOGICA LIMITED OPTION EXPIRING 30-JUN-2016
This search indicates that PYCOA options expiring 30/11/2016 are in fact traded options?
If these options were placed to the instos and sophs shouldn't they be unlisted and not show up on my normal search base?
Ann: Appendix 3B 1st Tranche A , page-9
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |